ERT Acquires Wearable Technology Specialist

ERT’s VP, Chief Strategy and Marketing Officer, Jim Mahon discusses the benefits of advanced wearables and other virtual trial technologies in the COVID-19 era, and how ERT is enabling the continuation of clinical trials – making clinical development more efficient and cost-effective.

Share